content

AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa  (Prasterone)

AMAG Pharmaceuticals, Inc. and Endoceutics, Inc. announced that they have entered into an exclusive license agreement that provides AMAG with U.S. commercial rights to...

Delmar Pharmaceuticals announces dosing of first patient in Phase two clinical trial of VAL-083

DelMar Pharmaceuticals, Inc , a biopharmaceutical company focused on the development and commercialization of new cancer therapies. Announced that patient dosing...

Aslan pharmaceuticals announces first patient enrolled in phase 1 study of Varlitinib in japan

ASLAN Pharmaceuticals , a biotech company focused on the development of immunotherapies and targeted agents for Asia prevalent tumour types announced that they are...

Aurobindo Pharma buys four biosimilar drugs from TL Biopharmaceutical

Aurobindo Pharma Limited is pleased to announce the acquisition of four cell culture derived biosimilar products from TL Biopharmaceutical AG. As part of this...

Ovid Therapeutics and NeuroPointDX Announce Collaboration to Identify Biomarkers for Angelman Syndrome

Ovid Therapeutics, a privately held biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, and NeuroPointDX, a...

Capsugel Announces Broad Commercial Availability of MASTâ„¢ System

Capsugel, a global leader in delivering high-quality, innovative dosage forms and solutions announced the broad commercial availability of its Modular Automated Sampling Technologyâ„¢ (MAST)...

QPSI Announces Acquisition Of Pharmaceutical Packaging Company, International Labs

Quality Packaging Specialists International, LLC (QPSI) has acquired 100% ownership of International Labs, LLC (INL) in an equity exchange transaction. Terms...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read